These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The distribution of the amplitude of miniature end-plate potentials in human muscle in vitro. Haynes J. Brain; 1971; 94(4):697-702. PubMed ID: 5132967 [No Abstract] [Full Text] [Related]
3. Correlation of single fibre EMG and muscle histochrmistry using an open biopsy recording technique. Schwartz MS, Moosa A, Dubowitz V. J Neurol Sci; 1977 Apr; 31(3):369-78. PubMed ID: 845618 [Abstract] [Full Text] [Related]
4. Muscular dystrophies and motoneuron diseases. A comparative electrophysiologic study. Panayiotopoulos CP, Scarpalezos S. Neurology; 1976 Aug; 26(8):721-5. PubMed ID: 945869 [Abstract] [Full Text] [Related]
5. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies. Farrugia ME, Kennett RP, Hilton-Jones D, Newsom-Davis J, Vincent A. Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556 [Abstract] [Full Text] [Related]
9. [Systolic time intervals of the left ventricle in neuromuscular diseases]. Pust B, Rakovec P. Z Kardiol; 1976 Aug; 65(8):708-12. PubMed ID: 969822 [Abstract] [Full Text] [Related]
15. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states. Kim YI, Goldner MM, Sanders DB. Muscle Nerve; 1980 May; 3(2):112-9. PubMed ID: 6245355 [Abstract] [Full Text] [Related]
16. Neurogenic muscle involvement in myasthenia gravis. A clinical and histopathological study. Oosterhuis H, Bethlem J. J Neurol Neurosurg Psychiatry; 1973 Apr; 36(2):244-54. PubMed ID: 4708458 [Abstract] [Full Text] [Related]